Home Vital Sentences Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Free PDFs:
Hepatology 2014 (5th Edition, 612 pages)
Short Guide to Hepatitis C (2014 Edition, 206 pages)

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    December 2014
  1. KOSARY CL, Altekruse SF, Ruhl J, Lee R, et al
    Clinical and prognostic factors for melanoma of the skin using SEER registries: Collaborative stage data collection system, version 1 and version 2.
    Cancer. 2014;120 Suppl S23:3807-3814.
    PubMed     Text format     Related articles    Abstract available


    September 2014
  2. LEE SM, Moon J, Redman BG, Chidiac T, et al
    Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.
    Cancer. 2014 Sep 23. doi: 10.1002/cncr.29055.
    PubMed     Text format     Related articles    Abstract available


    August 2014
  3. FLEMING NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, et al
    Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
    Cancer. 2014 Aug 25. doi: 10.1002/cncr.28981.
    PubMed     Text format     Related articles    Abstract available


  4. PRINTZ C
    Young people with non-melanoma skin cancers are at higher risk of other cancers.
    Cancer. 2014;120:2382-3.
    PubMed     Text format     Related articles   


    July 2014
  5. LAUNAY-VACHER V, Zimner-Rapuch S, Poulalhon N, Fraisse T, et al
    Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients.
    Cancer. 2014;120:2158-63.
    PubMed     Text format     Related articles    Abstract available


  6. CHAN MM, Haydu LE, Menzies AM, Azer MW, et al
    The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition.
    Cancer. 2014 Jul 1. doi: 10.1002/cncr.28851.
    PubMed     Text format     Related articles    Abstract available


    May 2014
  7. TISHLER RB
    Increased clarity on the use of radiotherapy in the management of desmoplastic melanoma.
    Cancer. 2014;120:1315-8.
    PubMed     Text format     Related articles   


    March 2014
  8. HAMID O, Ilaria R Jr, Garbe C, Wolter P, et al
    A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma.
    Cancer. 2014 Mar 26. doi: 10.1002/cncr.28635.
    PubMed     Text format     Related articles    Abstract available


    February 2014
  9. ASCIERTO PA, Margolin K
    Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma.
    Cancer. 2014 Feb 27. doi: 10.1002/cncr.28622.
    PubMed     Text format     Related articles   


  10. ACKERMAN A, Klein O, McDermott DF, Wang W, et al
    Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors.
    Cancer. 2014 Feb 27. doi: 10.1002/cncr.28620.
    PubMed     Text format     Related articles    Abstract available


  11. AZER MW, Menzies AM, Haydu LE, Kefford RF, et al
    Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib.
    Cancer. 2014;120:530-6.
    PubMed     Text format     Related articles    Abstract available


    January 2014
  12. TSENG J, Citrin DE, Waldman M, White DE, et al
    Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.
    Cancer. 2014 Jan 28. doi: 10.1002/cncr.28547.
    PubMed     Text format     Related articles    Abstract available


  13. PRINTZ C
    Consensus statement released for treating melanoma patients with immunotherapy.
    Cancer. 2014;120:3.
    PubMed     Text format     Related articles   


    December 2013
  14. AGARWALA SS, Eggermont AM, O'Day S, Zager JS, et al
    Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.
    Cancer. 2013 Dec 2. doi: 10.1002/cncr.28480.
    PubMed     Text format     Related articles    Abstract available


    October 2013
  15. GUADAGNOLO BA , Prieto V, Weber R, Ross MI, et al
    The role of adjuvant radiotherapy in the local management of desmoplastic melanoma.
    Cancer. 2013 Oct 18. doi: 10.1002/cncr.28415.
    PubMed     Text format     Related articles    Abstract available


  16. STROM T , Caudell JJ, Han D, Zager JS, et al
    Radiotherapy influences local control in patients with desmoplastic melanoma.
    Cancer. 2013 Oct 18. doi: 10.1002/cncr.28412.
    PubMed     Text format     Related articles    Abstract available


    September 2013
  17. COIT DG , Ernstoff MS, Busam KJ
    Is pediatric melanoma always malignant?
    Cancer. 2013 Sep 10. doi: 10.1002/cncr.28291.
    PubMed     Text format     Related articles   


  18. AVERBOOK BJ , Lee SJ, Delman KA, Gow KW, et al
    Pediatric melanoma: Analysis of an international registry.
    Cancer. 2013 Sep 10. doi: 10.1002/cncr.28289.
    PubMed     Text format     Related articles    Abstract available


  19. PRINTZ C
    Highlights from the ASCO annual meeting.
    Cancer. 2013;119:3104-5.
    PubMed     Text format     Related articles   


    August 2013
  20. BUCHEIT AD , Syklawer E, Jakob JA, Bassett RL Jr, et al
    Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
    Cancer. 2013 Aug 6. doi: 10.1002/cncr.28306.
    PubMed     Text format     Related articles    Abstract available


  21. PILOWSKY PM
    Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
    Cancer. 2013 Aug 6. doi: 10.1002/cncr.28248.
    PubMed     Text format     Related articles   


  22. TANG JY , Kubo J, Desai M
    Reply to aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
    Cancer. 2013 Aug 6. doi: 10.1002/cncr.28247.
    PubMed     Text format     Related articles   


  23. LUKE JJ , Callahan MK, Postow MA, Romano E, et al
    Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
    Cancer. 2013 Aug 2. doi: 10.1002/cncr.28282.
    PubMed     Text format     Related articles    Abstract available


    July 2013
  24. PRINTZ C
    Physicians Differ on the Use of Sentinel Lymph Node Biopsy for Melanoma: Published data receive various interpretations.
    Cancer. 2013;119:2515-6.
    PubMed     Text format     Related articles   


  25. PRINTZ C
    Target: melanoma: Skin cancer screenings hold promise to reduce mortality rates, but usage of widespread screening lags.
    Cancer. 2013;119:2359-60.
    PubMed     Text format     Related articles   


    May 2013
  26. HAMILTON R , Krauze M, Romkes M, Omolo B, et al
    Pathologic and gene expression features of metastatic melanomas to the brain.
    Cancer. 2013 May 21. doi: 10.1002/cncr.28029.
    PubMed     Text format     Related articles    Abstract available


  27. HU CY , Xing Y, Cormier JN, Chang GJ, et al
    Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
    Cancer. 2013;119:1900-7.
    PubMed     Text format     Related articles    Abstract available


    March 2013
  28. PRINTZ C
    New research on melanoma risk in red-haired people.
    Cancer. 2013;119:1118.
    PubMed     Text format     Related articles   


  29. GAMBA CA , Swetter SM, Stefanick ML, Kubo J, et al
    Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative.
    Cancer. 2013 Mar 11. doi: 10.1002/cncr.27817.
    PubMed     Text format     Related articles    Abstract available


    February 2013
  30. BAGARIA SP , Ray PS, Joseph RW, Heckman MG, et al
    Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
    Cancer. 2013 Feb 13. doi: 10.1002/cncr.27985.
    PubMed     Text format     Related articles    Abstract available


  31. WEBER JS , Dummer R, de Pril V, Lebbe C, et al
    Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: Detailed safety analysis from a phase 3 trial in patients with advanced melanoma.
    Cancer. 2013 Feb 7. doi: 10.1002/cncr.27969.
    PubMed     Text format     Related articles    Abstract available


    December 2012
  32. BEASLEY GM , Sharma K, Wong J, Miller M, et al
    A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.
    Cancer. 2012;118:6136-43.
    PubMed     Text format     Related articles    Abstract available


  33. PRINTZ C
    Strides in personalized medicine.
    Cancer. 2012;118:5722-3.
    PubMed     Text format     Related articles   


    September 2012
  34. PATEL SP , Lazar AJ, Papadopoulos NE, Liu P, et al
    Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.
    Cancer. 2012 Sep 12. doi: 10.1002/cncr.27790.
    PubMed     Text format     Related articles    Abstract available


  35. PRINTZ C
    Genetic test predicts whether eye cancer will spread.
    Cancer. 2012;118:4096.
    PubMed     Text format     Related articles   


    August 2012
  36. KOTTSCHADE LA , Suman VJ, Perez DG, McWilliams RR, et al
    A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group study, N0775.
    Cancer. 2012 Aug 22. doi: 10.1002/cncr.27760.
    PubMed     Text format     Related articles    Abstract available


  37. KIM KB
    Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
    Cancer. 2012 Aug 22. doi: 10.1002/cncr.27756.
    PubMed     Text format     Related articles   


    June 2012
  38. MURALI R , Brown PT, Kefford RF, Scolyer RA, et al
    Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma.
    Cancer. 2012 Jun 26. doi: 10.1002/cncr.27693.
    PubMed     Text format     Related articles    Abstract available


  39. PRINTZ C
    Declines in melanoma deaths occur in most-educated individuals.
    Cancer. 2012;118:3001.
    PubMed     Text format     Related articles   


    May 2012
  40. JOHANNESDOTTIR SA , Chang ET, Mehnert F, Schmidt M, et al
    Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: A population-based case-control study.
    Cancer. 2012 May 29. doi: 10.1002/cncr.27406.
    PubMed     Text format     Related articles    Abstract available


  41. CURIEL-LEWANDROWSKI C , Swetter SM, Einspahr JG, Hsu CH, et al
    Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: Evaluation of potential chemopreventive activity.
    Cancer. 2012 May 17. doi: 10.1002/cncr.27540.
    PubMed     Text format     Related articles    Abstract available


  42. MU E , Lange JR, Strouse JJ
    Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma.
    Cancer. 2012;118:2700-7.
    PubMed     Text format     Related articles    Abstract available


    April 2012
  43. KATALINIC A , Waldmann A, Weinstock MA, Geller AC, et al
    Does skin cancer screening save lives?: An observational study comparing trends in melanoma mortality in regions with and without screening.
    Cancer. 2012 Apr 19. doi: 10.1002/cncr.27566.
    PubMed     Text format     Related articles    Abstract available


    March 2012
  44. JAGTAP D , Rosenberg CA, Martin LW, Pettinger M, et al
    Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.
    Cancer. 2012 Mar 20. doi: 10.1002/cncr.27497.
    PubMed     Text format     Related articles    Abstract available


    January 2012
  45. HWA C , Price LS, Belitskaya-Levy I, Ma MW, et al
    Single versus multiple primary melanomas: Old questions and new answers.
    Cancer. 2012 Jan 13. doi: 10.1002/cncr.27407.
    PubMed     Text format     Related articles    Abstract available


    December 2011
  46. JAKOB JA , Bassett RL Jr, Ng CS, Curry JL, et al
    NRAS mutation status is an independent prognostic factor in metastatic melanoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26724.
    PubMed     Text format     Related articles    Abstract available


  47. SWETTER SM , Pollitt RA, Johnson TM, Brooks DR, et al
    Behavioral determinants of successful early melanoma detection: Role of self and physician skin examination.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26707.
    PubMed     Text format     Related articles    Abstract available


  48. POLLITT RA , Swetter SM, Johnson TM, Patil P, et al
    Examining the pathways linking lower socioeconomic status and advanced melanoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26706.
    PubMed     Text format     Related articles    Abstract available


    October 2011
  49. PRINTZ C
    Duke University researchers develop laser-based tool for melanoma.
    Cancer. 2011;117:4338-9.
    PubMed     Text format     Related articles   


    September 2011
  50. JENSEN TO , Schmidt H, Moller HJ, Donskov F, et al
    Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
    Cancer. 2011 Sep 22. doi: 10.1002/cncr.26511.
    PubMed     Text format     Related articles    Abstract available


    July 2011
  51. ERMAN AB , Collar RM, Griffith KA, Lowe L, et al
    Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Cancer. 2011 Jul 19. doi: 10.1002/cncr.26288.
    PubMed     Text format     Related articles    Abstract available


    June 2011
  52. ZHANG Z , Chen G, Cheng Y, Martinka M, et al
    Prognostic significance of RUNX3 expression in human melanoma.
    Cancer. 2011;117:2719-27.
    PubMed     Text format     Related articles    Abstract available


    May 2011
  53. KLUGER HM , Dudek AZ, McCann C, Ritacco J, et al
    A phase 2 trial of dasatinib in advanced melanoma.
    Cancer. 2011;117:2202-8.
    PubMed     Text format     Related articles   


  54. GADIOT J , Hooijkaas AI, Kaiser AD, van Tinteren H, et al
    Overall survival and PD-L1 expression in metastasized malignant melanoma.
    Cancer. 2011;117:2192-201.
    PubMed     Text format     Related articles   


  55. MCLAUGHLIN JM , Fisher JL, Paskett ED
    Marital status and stage at diagnosis of cutaneous melanoma: Results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006.
    Cancer. 2011;117:1984-93.
    PubMed     Text format     Related articles    Abstract available


    April 2011
  56. ZAKRZEWSKI J , Geraghty LN, Rose AE, Christos PJ, et al
    Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
    Cancer. 2011;117:1711-20.
    PubMed     Text format     Related articles    Abstract available


  57. KOTTSCHADE LA , Suman VJ, Amatruda T 3rd, McWilliams RR, et al
    A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group Study, N057E(1).
    Cancer. 2011;117:1704-10.
    PubMed     Text format     Related articles    Abstract available


  58. EIGENTLER TK , Figl A, Krex D, Mohr P, et al
    Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
    Cancer. 2011;117:1697-1703.
    PubMed     Text format     Related articles    Abstract available


  59. OTHUS M , Moon J, Margolin K
    Melanoma's deadly march to the brain: By what route, and can it be stopped?
    Cancer. 2011;117:1560-3.
    PubMed     Text format     Related articles   


    March 2011
  60. KIRKWOOD JM , Gonzalez R, Reintgen D, Clingan PR, et al
    A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26068.
    PubMed     Text format     Related articles    Abstract available


  61. SOSMAN JA , Moon J, Tuthill RJ, Warneke JA, et al
    A phase 2 trial of complete resection for stage IV melanoma: Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26111.
    PubMed     Text format     Related articles    Abstract available


  62. OLLILA DW
    A phase 2 trial of complete resection for stage IV melanoma : Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26118.
    PubMed     Text format     Related articles   


  63. KELLY P , Zagars GK, Cormier JN, Ross MI, et al
    Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: A 20-Year Experience.
    Cancer. 2011 Mar 28. doi: 10.1002/cncr.26088.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: